Found: 19
Select item for more details and to access through your institution.
Ethnic differences in normal retinal capillary density and foveal avascular zone measurements.
- Published in:
- International Ophthalmology, 2020, v. 40, n. 11, p. 3043, doi. 10.1007/s10792-020-01488-0
- By:
- Publication type:
- Article
Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting.
- Published in:
- Ophthalmologica, 2017, v. 236, n. 4, p. 207, doi. 10.1159/000453006
- By:
- Publication type:
- Article
Disruption in time projection and non-adherence to long-term therapies.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2363, doi. 10.2147/PPA.S180280
- By:
- Publication type:
- Article
Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. e90, doi. 10.1111/bjh.17046
- By:
- Publication type:
- Article
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 462, doi. 10.1111/bjh.14324
- By:
- Publication type:
- Article
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 18, p. 3364, doi. 10.1002/sim.10130
- By:
- Publication type:
- Article
Drug combinations screening using a Bayesian ranking approach based on dose–response models.
- Published in:
- Biometrical Journal, 2024, v. 66, n. 1, p. 1, doi. 10.1002/bimj.202200332
- By:
- Publication type:
- Article
Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 439, doi. 10.1111/ejh.13580
- By:
- Publication type:
- Article
Balancing Risk Versus Benefit in the Treatment of Waldenström's Macroglobulinemia Patients with Nucleoside Analogue–Based Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 71
- By:
- Publication type:
- Article
Patients' Perceived Importance of Medication and Adherence in Polypharmacy, a Quantitative, Cross-Sectional Study Using a Questionnaire Administered in Three Doctors' Private Practices in France.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 309, doi. 10.1007/s40801-023-00361-7
- By:
- Publication type:
- Article
TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S218, doi. 10.1016/j.clml.2018.07.084
- By:
- Publication type:
- Article
CLL Next Questions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S123, doi. 10.1016/j.clml.2018.06.079
- By:
- Publication type:
- Article
CLL State of the Art: An Update.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S110, doi. 10.1016/j.clml.2018.06.075
- By:
- Publication type:
- Article
In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E183, doi. 10.1002/ajh.25480
- By:
- Publication type:
- Article
Characteristics of chronic lymphocytic leukemia patients achieving 5+ years of remission after FC-based first-line treatment: Retrospective observations from the FILO group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. E24, doi. 10.1002/ajh.24951
- By:
- Publication type:
- Article
Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years.
- Published in:
- American Journal of Hematology, 2000, v. 64, n. 3, p. 232, doi. 10.1002/1096-8652(200007)64:3<232::AID-AJH20>3.0.CO;2-#
- By:
- Publication type:
- Article
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
- Published in:
- 2009
- By:
- Publication type:
- journal article
Feasibility of combining two individualized lung recruitment maneuvers at birth for very low gestational age infants: a retrospective cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article